Back to News
Market Impact: 0.45

Down Around 47% From Its High, Should You Buy Chewy Stock Right Now?

CHWYNVDAINTCNFLXNDAQ
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsConsumer Demand & RetailAnalyst EstimatesInvestor Sentiment & PositioningMarket Technicals & Flows
Down Around 47% From Its High, Should You Buy Chewy Stock Right Now?

Chewy reported FY2025 net sales of $12.6 billion, up ~6%, and operating income more than doubled to $254.3 million (from $112.6M). Management guides FY2026 revenue up ~8% to $13.6–$13.75 billion, slightly above analyst expectations, and the stock trades at a forward P/E of ~17 versus the S&P 500's >20. Shares are down ~21% YTD and ~47% from their 52-week high, making the company appear relatively inexpensive given resilient fundamentals and customer growth.

Analysis

Chewy’s structural advantage is in recurring, necessity-like spend wrapped in a high-frequency e‑commerce engine — that translates into optionality on unit economics: every 5–10% improvement in fulfillment density or retention can flow nearly full-through to EBITDA because of sizable fixed-cost buckets in warehousing and last-mile. The second-order winners are regional warehouses and third‑party logistics partners who scale with Chewy; losers include local independents and to a lesser extent brick-and-mortar specialty chains that lack subscription stickiness. Large CPG suppliers (Mars, Nestlé) sit on both risks and opportunities: they can squeeze margins via negotiated pricing or accelerate private‑label distribution through Chewy’s platform, changing margin mix within 12–24 months. Key risks are asymmetric and time‑phased. In the next 30–90 days, consensus is fragile around quarterly cadence — one soft active‑customer or retargeting CAC print can move the stock 15–30% on sentiment alone. Over 6–24 months, structural threats are supplier price resets, a re‑acceleration of customer acquisition costs as promotions normalize, or a macro shock that compresses discretionary bundling (treats/toys) even if staple food is sticky. Conversely, non‑linear upside catalysts include faster cross‑sell into telehealth/vet services and margin mix shifts from private label — each could add several hundred basis points to operating margin over 2–3 years. The market appears to underprice optionality from higher retention and fixed‑cost leverage while overweighing short‑term sentiment risk. That asymmetry permits constructing both directional and relative‑value trades that monetize a mean‑reversion in sentiment and a multi‑quarter earnings upgrade path, while actively hedging headline volatility from earnings and guidance.